SCHEMBL21783763

SCHEMBL21783763

CON(C)C(=O)CC1CCN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.44
NR1H2 P55055 1/20 0.42
JAK2 O60674 1/20 0.42
JAK1 P23458 1/20 0.42
KDM4E B2RXH2 1/20 0.41
PKM P14618 1/20 0.41
USP30 Q70CQ3 3/20 0.41
HPGD P15428 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
GLS O94925 2/20 0.41
RECQL P46063 1/20 0.39
EPHX1 P07099 1/20 0.39
IDO1 P14902 1/20 0.39
TDO2 P48775 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29365972 1.00 GPR119 (0.44) GPR119NR1H2JAK2JAK1KDM4E
SCHEMBL21783667 1.00 GPR119 (0.44) GPR119NR1H2JAK2JAK1KDM4E
SCHEMBL1329227 0.92 GPR119 (0.48) GPR119KDM4EPKMHPGDALDH1A1
SCHEMBL16545031 0.89 NR1H2 (0.49) GPR119NR1H2JAK2JAK1HPGD
SCHEMBL25835179 0.89 GPR119 (0.36) GPR119NR1H2JAK2JAK1KDM4E
SCHEMBL34474175 0.88 GPR119 (0.46) GPR119NR1H2JAK2JAK1KDM4E
SCHEMBL31209154 0.88 GPR119 (0.46) GPR119NR1H2JAK2JAK1KDM4E
SCHEMBL3561605 0.88 GPR119 (0.46) GPR119NR1H2JAK2JAK1KDM4E
SCHEMBL25314409 0.83 NR1H2 (0.48) GPR119NR1H2KDM4EPKMUSP30
SCHEMBL25311767 0.83 NR1H2 (0.48) GPR119NR1H2KDM4EPKMUSP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020081154-A1 INHIBITORS OF ανβ6 INTEGRIN MORPHIC THERAPEUTIC, INC. (US) 2020-04-23 WO disclosed
WO-2020047208-A1 INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN MORPHIC THERAPEUTIC, INC. (US) 2020-03-05 WO disclosed